HHLR ADVISORS, LTD.HHLR ADVISORS, LTD.

Institutional investor · Portfolio as of Q1 2026

SEC EDGAR SourceSEC Filings

Top Holdings38 positions

Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
PDDPDD
ADR

PDD HOLDINGS INC

4.2M$425.6M25.4%$114.13-25.41%
16 qtrssince 2022-Q2
Decreased
0
BABABABA
ADR

ALIBABA GROUP HLDG LTD

2.5M$307.8M18.4%$146.94-23.56%
16 qtrssince 2022-Q2
Decreased
0
ONCONC
ADR

BEONE MEDICINES LTD

1M$307.2M18.4%$134.02+122.87%
30 qtrssince 2018-Q4
Unchanged
0
FUTUFUTU
ADR

FUTU HLDGS LTD

1.4M$194.1M11.6%$95.17+1.22%
8 qtrssince 2024-Q2
Decreased
0
LEGNLEGN
ADR

LEGEND BIOTECH CORP

6M$108.3M6.5%$50.33-46.19%
24 qtrssince 2020-Q2
Unchanged
0

ARRIVENT BIOPHARMA INC

3.9M$90.6M5.4%$17.95+87.74%
9 qtrssince 2024-Q1
Unchanged
0
BEKEBEKE
ADR

KE HLDGS INC

4.2M$63.4M3.8%$21.74-28.37%
23 qtrssince 2020-Q3
Unchanged
0
CWANCWANDelisted

CLEARWATER ANALYTICS HLDGS I

1.4M$32.3M1.9%$22.00+10.68%
4 qtrssince 2025-Q2
Unchanged
0

CYTEK BIOSCIENCES INC

6.7M$29.1M1.7%$20.96-77.96%
19 qtrssince 2021-Q3
Unchanged
0

MARVELL TECHNOLOGY INC

171,033$16.9M1.0%$77.51+204.23%
1 qtr
New
65
YSYSG
ADR

YATSEN HLDG LTD

4.9M$15M0.9%$10.59-65.82%
22 qtrssince 2020-Q4
Unchanged
0
NBPNBP
ADR

NOVABRIDGE BIOSCIENCES

6M$14.7M0.9%$47.24-95.98%
23 qtrssince 2020-Q3
Unchanged
0

MAZE THERAPEUTICS INC

366,028$10.9M0.7%$11.42+167.69%
5 qtrssince 2025-Q1
Decreased
0

CONTINEUM THERAPEUTICS INC

669,337$8.7M0.5%$17.61-13.74%
8 qtrssince 2024-Q2
Unchanged
0
APIAPI
ADR

AGORA INC

2.1M$7.4M0.4%$4.20+0.48%
6 qtrssince 2024-Q4
Unchanged
0

WEBULL CORP

1.5M$7.2M0.4%$10.83-31.86%
4 qtrssince 2025-Q2
Decreased
0
TSMTSM
ADR

TAIWAN SEMICONDUCTOR MANUFAC

15,520$5.2M0.3%$314.14+38.19%
2 qtrssince 2025-Q4
Increased
43

SAGIMET BIOSCIENCES INC

724,800$3.8M0.2%$8.80-16.25%
11 qtrssince 2023-Q3
Unchanged
0
TUYATUYA
ADR

TUYA INC

1.6M$3.6M0.2%$19.21-90.42%
21 qtrssince 2021-Q1
Unchanged
0

GE AEROSPACE

10,043$2.8M0.2%$204.11+76.02%
9 qtrssince 2024-Q1
Unchanged
0
Showing 20 of 38 results.18 more with Pro.PROUpgrade to see all →
$1.7B
AUM
38
Positions
Q1 2026
Filing
Rating · 2.0
Quarterly Portfolio Change
-37%Q4'24$2.9B+23%Q1'25$3.5B-12%Q2'25$3.1B+32%Q3'25$4.1B-24%Q4'25$3.1B-46%Q1'26$1.7B
Activity profile
$ moved · Q1'26
New2%Increased0%Decreased98%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.4 years
<1Q16%1-4Q16%1-2Y5%2Y+63%

HHLR ADVISORS, LTD. manages $1.7B across 38 positions as of Q1 2026. Top holdings: PDD (25.4%), BABA (18.4%), ONC (18.4%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q1 2026 Summary

Active quarter - 9 new positions, 4 exits, 2 increased. Top move: MRVL (NEW, conviction 65). Portfolio: $1.7B across 38 positions.

Top holdings by portfolio weight

Total AUM$2B
PDD25.44%
BABA18.40%
ONC18.36%
FUTU11.60%
LEGN6.47%
AVBP5.42%
BEKE3.79%
CWAN1.93%
CTKB1.74%
MRVL1.01%
Other0.90%

Portfolio allocation by GICS sector

Sectors10
Consumer Cyclical44.08%
Healthcare34.48%
Financial Services11.60%
Technology4.71%
Real Estate3.79%
Consumer Defensive0.95%
Industrials0.17%
Basic Materials0.13%
Utilities0.04%
Unknown0.04%

Behavioral investing profile

7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record30
Conviction42
Concentration100
Upgrade to see all dimensions

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used